SAN FRANCISCO (GenomeWeb) – Direct Genomics has demonstrated that its single-molecule sequencing platform, GenoCare, can sequence Escherichia coli, and the firm is gearing up to commercialize its platform for clinical use.
SAN FRANCISCO (GenomeWeb) – Direct Genomics has demonstrated that its single-molecule sequencing platform, GenoCare, can sequence Escherichia coli, and the firm is gearing up to commercialize its platform for clinical use.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.